|
|
122:
|
Takeuchi T, Harigai M, Tanaka Y, Yamanaka H, Ishiguro N, Yamamoto K, Miyasaka N, Koike T, Kanazawa M, Oba T, Yoshinari T, Baker D. Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks. Ann Rheum Dis [Internet]. 2013 Sep [cited 2018 Nov 8];72(9):1488–1495. Available from: http://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2012-201796
|
